John Hansen, MD
Urology · Sun City West, AZNPI 1679592372
Payments from drug & device makers
Across 130 payments — averaging $54.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Teleflex LLC$2K
- Boston Scientific$964
- Procept Biorobotics Corporation$422
- Astellas Pharma US Inc$360
- Axonics, Inc.$306
- Intuitive Surgical$282
- plus $2K from 27 others
What the payments were for
- Consulting fees$1001%
- Speaking & faculty fees$1813%
- Travel & lodging$96814%
- Food & beverage$5,77882%
- Education$150%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Teleflex LLC | 16 | $2,249 |
| Boston Scientific | 19 | $964 |
| Procept Biorobotics Corporation | 7 | $422 |
| Astellas Pharma US Inc | 13 | $360 |
| Axonics, Inc. | 7 | $306 |
| Intuitive Surgical | 2 | $282 |
| Coloplast | 14 | $280 |
| Pfizer | 5 | $261 |
| Bayer | 6 | $235 |
| Urogen Pharma, Inc. | 5 | $194 |
| Johnson & Johnson | 3 | $186 |
| Pacira Pharmaceuticals Incorporated | 1 | $181 |
| Conmed Corporation | 1 | $148 |
| Progenics Pharmaceuticals, Inc. | 2 | $142 |
| Olympus America Inc. | 1 | $133 |
| Innovation Technologies Inc | 1 | $116 |
| Comsort, Inc | 1 | $100 |
| Endo USA, Inc. | 4 | $77 |
| Ferring Pharmaceuticals Inc. | 4 | $60 |
| Urovant Sciences Inc | 2 | $48 |
| KARL Storz Endoscopy-america | 1 | $46 |
| Sumitomo Pharma America, Inc. | 2 | $41 |
| Tolmar, Inc. | 2 | $35 |
| Endo Pharmaceuticals Inc. | 2 | $31 |
| AbbVie | 1 | $22 |
| Myriad Genetic Laboratories, Inc. | 1 | $21 |
| Abbott | 1 | $20 |
| Merck | 1 | $18 |
| Sun Pharmaceutical Industries Inc. | 1 | $14 |
| Accord Healthcare, Inc. | 1 | $14 |
| Covidien LP | 1 | $12 |
| Biotissue Holdings Inc. | 1 | $12 |
| Healthtronics Stone Solutions, LLC | 1 | $10 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- UroLift$1,597
- Da Vinci Surgical System$242
- XTANDI$220
- EXPAREL$181
- AQUABEAM SYSTEM$176
- AIRSEAL$148
- GENERAL ERECTILE DYSFUNCTION$140
- RYBREVANT$140
- CARVYKTI$140
- Bulkamid$138
- Axonics$138
- iTIND System$133
- ZUSDURI$129
- Nubeqa$125
- Veozah$125
- UroLift System$124
- PYLARIFY$122
- Irrisept$116
- LithoVue$114
- TITAN$103
How this compares
$7,042 in reported general payments places this provider in the 60th percentile of 269 urology providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 56 | $62,694 |
| GemtesaVibegron | 18 | $11,142 |
| Tamsulosin Hcl | 391 | $8,759 |
| Methenamine Hippurate | 30 | $3,090 |
| Finasteride | 201 | $2,760 |
| Alfuzosin Hcl ErAlfuzosin Hcl | 96 | $2,423 |
| Oxybutynin Chloride ErOxybutynin Chloride | 100 | $2,219 |
| Solifenacin Succinate | 16 | $910 |
| NitrofurantoinNitrofurantoin Macrocrystal | 13 | $910 |
| Bethanechol Chloride | 17 | $870 |
| Doxazosin Mesylate | 19 | $330 |
| Oxybutynin Chloride | 28 | $273 |
| Cephalexin | 18 | $210 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 73 | $159 |
| Imipramine Hcl | 12 | $137 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Astellas Pharma US IncMyrbetriq | $360 | $62,69456 claims |
| Sumitomo Pharma America, Inc.Gemtesa | $41 | $11,14218 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 269 urology providers in Arizona.
Other urology in Sun City West
- Curtis DunsheeTucson$16M
- Mark TysonScottsdale$4.9M
- Kalpesh PatelTucson$2.3M
- Susan KalotaTucson$1.2M
- Mitchell HumphreysPhoenix$1.1M
- Donald LammPhoenix$403K
- David KaplanLitchfield Park$376K
- Shawn BlickGoodyear$336K
- Jack AndrewsPhoenix$331K
- Daniel JaffeePhoenix$280K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.